What are the causes of proximal muscle weakness in a man with prostate cancer?

Causes of Proximal Muscle Weakness in Prostate Cancer

The primary causes of proximal muscle weakness in men with prostate cancer are androgen deprivation therapy (ADT)-induced sarcopenia and muscle atrophy, metastatic disease (particularly spinal cord compression from vertebral metastases), and rarely, paraneoplastic inflammatory myopathy or drug-induced myositis.

ADT-Related Muscle Loss (Most Common)

ADT is the predominant cause of proximal muscle weakness in prostate cancer patients, producing multiple mechanisms of muscle deterioration:

• Sarcopenia and muscle atrophy: ADT causes significant lean muscle mass loss, with documented reductions in muscle cross-sectional area of the sartorius, quadriceps, and rectus femoris muscles within 14-20 weeks of treatment initiation 1
• Muscle quality deterioration: Beyond size reduction, ADT decreases muscle attenuation by 18.9%, reflecting increased intramuscular lipid infiltration and reduced muscle quality 1
• Accelerated frailty syndrome: ADT produces a clinical syndrome overlapping with geriatric frailty, characterized by unintentional lean weight loss, weakness, slow walking speed, exhaustion, and low physical activity 2
• Metabolic consequences: ADT causes insulin resistance and metabolic syndrome, which further compromise muscle function 3

The ESMO guidelines explicitly recognize that ADT causes muscle loss as a significant adverse effect requiring monitoring 3.

Metastatic Disease Complications

Spinal cord compression from vertebral metastases represents a critical cause of proximal weakness requiring urgent evaluation:

• High prevalence: Spinal cord compression is common even in asymptomatic patients with metastatic prostate cancer and spinal metastases 3
• Urgent imaging required: MRI of the spine is very strongly recommended for men with castration-resistant prostate cancer (CRPC), vertebral metastases, and neurological symptoms 4
• Subclinical detection: MRI screening is recommended for men with CRPC and vertebral metastases even without neurological symptoms to detect subclinical cord compression 4

Bone metastases can cause pain and functional impairment contributing to weakness through:

• Direct skeletal involvement limiting mobility 3
• Pathological fractures affecting weight-bearing capacity 3

Paraneoplastic and Drug-Induced Myopathy (Rare)

Inflammatory myopathy can occur as a paraneoplastic phenomenon or drug reaction:

• Leuprolide-induced myopathy: Rare cases of proximal inflammatory myopathy with severe rhabdomyolysis and renal failure have been reported following leuprolide acetate administration 5
• Paraneoplastic presentation: Metastatic prostate cancer can mimic polymyalgia rheumatica with proximal muscle pain, weakness, and elevated inflammatory markers 6
• Myasthenia gravis association: Extremely rare cases of myasthenia gravis presenting with ptosis, diplopia, and proximal weakness have been reported with prostatic cancer 7

Diagnostic Approach

When evaluating proximal muscle weakness in prostate cancer patients, systematically assess:

1. ADT exposure history: Duration and type of hormonal therapy (most likely cause if on ADT >3-6 months) 1, 2
2. Neurological examination: Assess for upper motor neuron signs, sensory level, or bowel/bladder dysfunction suggesting cord compression 4, 3
3. Imaging for metastases: Urgent spinal MRI if any neurological symptoms; consider screening MRI if vertebral metastases known 4
4. Laboratory evaluation: Creatine kinase (elevated in inflammatory myopathy or rhabdomyolysis), inflammatory markers (ESR, CRP), and renal function 5, 6
5. Temporal relationship: Acute onset suggests cord compression or inflammatory myopathy; gradual progression over months suggests ADT-related sarcopenia 1, 2

Management Implications

Exercise intervention is strongly recommended for ADT-related muscle loss:

• Men starting ADT should be informed that regular exercise reduces fatigue and improves quality of life 4
• Resistance training specifically attenuates muscle loss and improves long-term outcomes in men receiving ADT 8
• Weight-bearing exercise is recommended as a lifestyle measure for men on ADT 3

For suspected cord compression, immediate action is required:

• Urgent MRI and neurosurgical consultation 4
• External beam radiotherapy for symptomatic bone metastases 4

For inflammatory myopathy, drug withdrawal and corticosteroid therapy may be necessary 5.